Target intelligence / Profile preview

Telomere-associated chromatin

Molecular classification
Chromatin, Protein-DNA complex, Epigenetic regulator
01

Overview

Telomere-associated chromatin is a specialized nucleoprotein structure located at the termini of eukaryotic chromosomes, primarily composed of repetitive DNA sequences (TTAGGG in humans) and the six-protein shelterin complex (de Lange, 2005, Genes & Development). This chromatin structure is essential for maintaining genomic integrity by masking chromosome ends from the DNA damage response machinery, thereby preventing deleterious end-to-end fusions and degradation (O'Sullivan & Karlseder, 2010, Nature Reviews Molecular Cell Biology). It also regulates the access of telomerase, the enzyme responsible for extending telomeres, which is a critical factor in cellular immortality (Blackburn, 2001, Nature). In the context of disease, telomere-associated chromatin is frequently dysregulated; cancer cells often exploit telomere maintenance mechanisms to achieve unlimited proliferative potential, while telomere shortening is a hallmark of aging and various telomeropathies like Dyskeratosis congenita (Armanios & Blackburn, 2012, Nature Reviews Genetics). Therapeutic targeting of this chromatin involves the use of G-quadruplex stabilizers, which lock telomeric DNA into structures that inhibit telomerase, or small molecules designed to disrupt shelterin proteins like TRF2 (Neidle, 2017, Nature Reviews Chemistry). Such interventions aim to induce telomere crisis, leading to selective apoptosis or senescence in malignant cells.

Other names
Telomeric chromatinShelterin complexTelomere-associated proteinsTelomeric nucleoprotein complex
02

Mechanism of action

Stabilization of G-quadruplex structures to prevent telomerase binding, disruption of the shelterin complex to induce telomere dysfunction, and inhibition of telomerase enzymatic activity to promote telomere shortening.

03

Biological functions

Chromosome protectionTelomere maintenanceGenome stabilityRegulation of cellular senescenceDNA damage response inhibition
04

Disease associations

CancerAgingDyskeratosis congenitaIdiopathic pulmonary fibrosisAplastic anemia
05

Safety considerations

Hematologic toxicity (e.g., neutropenia, thrombocytopenia)Potential for genomic instability in healthy cellsImpaired wound healingAccelerated aging phenotypes
06

Interacting drugs

Imetelstat

4 more in the full profile.

07

Biomarkers

Telomere lengthTelomere-dysfunction induced foci (TIFs)TRF2 expression levelshTERT expression

Beyond the preview

Go deeper on Telomere-associated chromatin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Telomere-associated chromatin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call